EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin…more
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin…more
Latest RNS from EKF Diagnostics Holdings plc
- holdingsHolding(s) in Company
- interim_resultsInterim Results
- trading_updateH1 2026 Trading Update
Analyst consensus: Buy
As of 23 Sept 2026, 3 analysts rate EKF Diagnostics Holdings plc a Buy, with 100% buy ratings and a mean price target of 35p (range 34p–35p), +30% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 36p against a current price of 25p (+44%), based on EV/EBITDA.